Disproportionality analysis of pregnancy janus kinase inhibitor reports in VigiBase

ENTIS affiliated researchers from the Swiss TIS (University of Lausanne/University of Bern), Ente Ospedaliero Cantonale (Lugano) and Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne) have published a disproportionality analysis of the VigiBase World Health Organization global pharmacovigilance database, to identify signals of disproportionate reporting for pregnancy-related adverse drug reactions associated with janus kinase inhibitors. More information is available here.

Photo by Camylla Battani on Unsplash